The kidney is the major site of S-adenosylhomocysteine disposal in humans.

[1]  J. Loscalzo,et al.  The treatment of hyperhomocysteinemia. , 2009, Annual review of medicine.

[2]  J. Carrero,et al.  Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[3]  W. Ling,et al.  Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine. , 2008, The Journal of nutrition.

[4]  M. Koury,et al.  S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? , 2007, The American journal of clinical nutrition.

[5]  P. Molloy,et al.  DNA hypomethylation and human diseases. , 2007, Biochimica et biophysica acta.

[6]  W. Dupont,et al.  Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children. , 2006, Metabolism: clinical and experimental.

[7]  M. Vettore,et al.  Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy. , 2005, Diabetes.

[8]  R. Castro,et al.  Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC , 2005, Journal of Molecular Medicine.

[9]  R. Allen,et al.  Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotope-dilution liquid chromatography-mass spectrometry. , 2004, Clinical chemistry.

[10]  C. Stehouwer,et al.  Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine. , 2004, American journal of physiology. Renal physiology.

[11]  M. D'Esposito,et al.  Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia , 2003, The Lancet.

[12]  J. Loscalzo,et al.  Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia , 2002, Vascular medicine.

[13]  M. Koury,et al.  Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. , 2001, The American journal of clinical nutrition.

[14]  M. Bibby,et al.  Regulation of homocysteine metabolism in a mouse colon tumour model. , 2001 .

[15]  N. Maeda,et al.  Endothelial Dysfunction and Elevation of S-Adenosylhomocysteine in Cystathionine &bgr;-Synthase–Deficient Mice , 2001, Circulation research.

[16]  D. Jacobsen,et al.  Homocysteine in health and disease , 2001 .

[17]  H. Osswald,et al.  Localization of S-adenosylhomocysteine Hydrolase in the Rat Kidney , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  A. Donker,et al.  Homocysteine and methionine metabolism in ESRD: A stable isotope study. , 1999, Kidney international.

[19]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[20]  C. Berne,et al.  Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. , 1999, Kidney international.

[21]  Hong Wang,et al.  Homocysteine and hypomethylation. A novel link to vascular disease. , 1999, Trends in cardiovascular medicine.

[22]  W. Haefeli,et al.  Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  J. Finkelstein.  The Regulation of Homocysteine Metabolism , 1997 .

[24]  M. Vettore,et al.  Kidney, splanchnic, and leg protein turnover in humans. Insight from leucine and phenylalanine kinetics. , 1996, The Journal of clinical investigation.

[25]  V. Zappia,et al.  Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine. , 1993, The Journal of clinical investigation.

[26]  P. Crooks.  Biological methylation and drug design. Experimental and clinical roles of s-adenosylmethionine , 1988 .

[27]  R. Borchardt,et al.  Biological Methylation and Drug Design , 1986, Experimental Biology and Medicine.

[28]  P. Ueland,et al.  S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in various tissues of mice given injections of 9-beta-D-arabinofuranosyladenine. , 1983, Cancer research.

[29]  R. DeFronzo,et al.  Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. , 1980, The American journal of physiology.

[30]  D. Wilcken,et al.  The pathogenesis of coronary artery disease. A possible role for methionine metabolism. , 1976, The Journal of clinical investigation.

[31]  M. Friedman.  Pathogenesis of coronary artery disease , 1969 .